A Time to Stop Prescribing Antioxidant Vitamins to Prevent and Treat Heart Disease?
نویسندگان
چکیده
منابع مشابه
A time to stop prescribing antioxidant vitamins to prevent and treat heart disease?
The article by Cheung et al, 1 “Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL” in this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, demonstrates a possibly important and troubling observation. The addition of an antioxidant “cocktail,” comprising vitamins E and C, b-carotene, and selenium, for...
متن کاملAntioxidant vitamins and the prevention of coronary heart disease.
Clinical use of antioxidant vitamin supplementation may help to prevent coronary heart disease (CHD). Epidemiologic studies find lower CHD morbidity and mortality in persons who consume larger quantities of antioxidants in foods or supplements. Clinical trials indicate that supplementation with certain nutrients is beneficial in reducing the incidence of CHD events. Recent studies show that sup...
متن کاملEffectiveness of Electronic Health Care and Drug Monitoring Program to Prevent COVID-19 and Adherence to Therapeutic Regimen in Patients with Ischemic Heart Disease- A Pilot Study
Background and Aim: One of the high-risk groups due to the prevalence of COVID-19 are patients with chronic heart disease. The aim of this study was to evaluate the effectiveness of the electronic health care and drug monitoring program to prevent COVID-19 and adherence to therapeutic regimen of patients with chronic heart disease (ischemic heart disease). Methods: This pilot study is a quasi-e...
متن کاملTargeting gut flora to treat and prevent disease.
There's evidence to suggest that probiotics, prebiotics, and a high-fiber diet can help mange various illnesses. Here's how to translate gut flora research into practice.
متن کاملResource Effective Strategies to Prevent and Treat Cardiovascular Disease.
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries. The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in low- and middle-income countries. Barriers at the patient, healthcare provider, and health system level prevent the implement...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arteriosclerosis, Thrombosis, and Vascular Biology
سال: 2001
ISSN: 1079-5642,1524-4636
DOI: 10.1161/atvb.21.8.1253